We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| GW Pharm. | LSE:GWP | London | Ordinary Share | GB0030544687 | ORD 0.1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 735.00 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jul 2019 to Jul 2024
TIDMGWP
RNS Number : 0994A
GW Pharmaceuticals PLC
17 December 2014
GW Pharmaceuticals PLC Director/PDMR Shareholding
17 December 2014
GW Pharmaceuticals PLC ("GW Pharmaceuticals" or the "Company")
NOTIFICATION OF INTERESTS OF DIRECTORS AND CONNECTED PERSONS
Porton Down, UK, 17 December 2014: GW Pharmaceuticals (AIM: GWP) hereby provides notification that the Company has today been notified that earlier in the day Mr Justin Gover, Chief Executive Officer of the Company, and his wife have completed a transfer of the ownership of 2,143,314 0.1 pence ordinary shares of GW Pharmaceuticals plc to The Gover Family Investment LLP, an investment vehicle in which they jointly retain a 100% interest.
This transfer, representing 0.9% of the Company's current issued share capital, took place for nil consideration and was completed when the market price of the Company's ordinary shares was 353 pence per share.
Following this notification Mr Gover's beneficial interest in GW Pharmaceuticals plc ordinary shares of 0.1 pence each remains unchanged at 2,143,315 shares, representing 0.9% of the Company's current issued share capital.
The total number of shares outstanding in the Company is 236,800,996 ordinary shares of 0.1 pence each.
Enquiries:
GW Pharmaceuticals PLC Tel: +44 (0)1980 557 000
Adam George, Company Secretary
Peel Hunt LLP (Nominated Adviser) Tel: +44 (0)207 418 8900
James Steel/Claire Terlouw
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFSRFDLDLIS
1 Year Gw Pharmaceuticals Chart |
1 Month Gw Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
